Načítá se...
RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis
Male osteoporosis is an increasingly recognized problem in aging men. A common cause of male osteoporosis is hypogonadism. Thousands of men with prostate cancer are treated with androgen deprivation therapy, a treatment that dramatically reduces serum testosterone and causes severe hypogonadism. Men...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE-Hindawi Access to Research
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3196262/ https://ncbi.nlm.nih.gov/pubmed/22013547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/941310 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|